STOK Historical Earnings image   This STOK historical earnings page last updated 11/7/2024
STOK Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202411/5/20240.00B
Q2 20248/7/20240.00B
Q1 20245/6/20240.00B
Q4 20233/25/20240.00B
Q3 202311/7/20230.00B
Q2 20238/7/2023-0.00B
Q1 20235/4/20230.01B
Q4 20223/6/20230.00B
Q3 202211/14/20220.00B
Q2 20228/8/20220.00B
Q1 20225/10/20220.00B
Q4 20213/10/2022NA
Q3 202111/8/2021NA
Q2 20218/10/2021NA
Q1 20215/10/2021NA
Q4 20203/9/2021NA
Q3 202011/12/2020NA
Q2 20208/10/2020NA
Q1 20205/15/2020NA
Q4 20193/23/2020NA
Q3 201911/12/2019NA
Q2 20198/14/2019NA
STOK Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202411/5/2024-0.470
Q2 20248/7/2024-0.460
Q1 20245/6/2024-0.570
Q4 20233/25/2024-0.600
Q3 202311/7/2023-0.550
Q2 20238/7/2023-0.690
Q1 20235/4/2023-0.530
Q4 20223/6/2023-0.650
Q3 202211/14/2022-0.660
Q2 20228/8/2022-0.630
Q1 20225/10/2022-0.660
Q4 20213/10/2022-0.660
Q3 202111/8/2021-0.610
Q2 20218/10/2021-0.600
Q1 20215/10/2021-0.460
Q4 20203/9/2021-0.420
Q3 202011/12/2020-0.410
Q2 20208/10/2020-0.390
Q1 20205/15/2020-0.340
Q4 20193/23/2020-0.090
Q3 201911/12/2019-0.260
Q2 20198/14/2019-1.540
Quotes delayed 20 minutes

Email EnvelopeFree STOK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Stoke Therapeutics (STOK) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

STRO Historical Earnings
STRR Historical Earnings
STSA Historical Earnings
STTK Historical Earnings
SUPN Historical Earnings
SURF Historical Earnings
SVRA Historical Earnings
SWAV Historical Earnings
SWTX Historical Earnings
SYBX Historical Earnings
What was the record high STOK historical earnings result?
In terms of earnings or revenue, what is the best STOK historical earnings result that Stoke Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest STOK historical earnings result was set in Q4 2019, when Stoke Therapeutics posted results of -0.090/share. The most successful revenue quarter within our data set was Q1 2023 when Stoke Therapeutics reported revenue of 0.01B.

What was the lowest Stoke Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest STOK has reported, and when?

✔️Accepted answer: Within our data set, the lowest STOK historical earnings result was set in Q2 2019, when Stoke Therapeutics posted results of -1.540/share. The smallest revenue quarter within our data set was Q2 2023 when Stoke Therapeutics reported revenue of -0.00B.

On this page we presented the STOK historical earnings date information for Stoke Therapeutics. Reviewing that STOK Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2019, when STOK posted gaap of -0.090/share. Meanwhile the lowest STOK historical earnings result was in Q2 2019, when STOK posted gaap of -1.540/share. Moving to Stoke Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2023 when STOK reported 0.01B in revenue, while the smallest revenue quarter was Q2 2023 when STOK reported -0.00B in revenue.

For self directed investors doing their due diligence on STOK or any other given stock, their research can benefit from looking into all of the Stoke Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Stoke Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for STOK. Thanks for visiting, and the next time you need to research STOK historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: VE Videos, MSEX Insider Buying, Top Ten Hedge Funds Holding ALUR.

 

STOK Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.